Helping diabetes patients

live a healthier life.

arterioscope is an easy-to-use, AI-powered software solution designed for healthcare professionals and the pharmaceutical industry. By integrating and analyzing different data sources such as ECG, PPG, ICG, or IPG, we are diagnosing cardiovascular complications non-invasively with an accuracy of up to 97%.

The core of our patented technology is an advanced

AI-algorithm, capable to interpret signals such as ECG, PPG, ICG or IPG and convert them into patient-specific models.

blockchain outline gradient icon

Advanced AI-Algorithm

Our trained AI-Algorithm is able to use the measurement data of standard devices to diagnose diabetes complications such as arteriosclerosis, valvular heart disease and other cardiovascular pathologies with an accuracy up to 97%.

Digital Twins Icon

Digital Twins

With our patient-specific system analysis we are able to detect any disease correlated to pathological hemodynamics. With the help of our imaging technology we are able to create digital twins for advanced blood-flow simulation.

heart diagnostics

Preventive diagnostics

arterioscope is transforming diabetes healthcare with a revolutionary, preventive approach to diagnosing complications. Our AI-driven solutions outperform Ultrasound, CT, and MRI in cost, and efficiency.

Our Customer Segments

Heart Monitor with ECG Lines on the Background of Critical Patie


Doctor with health insurance healthcare graphic.


Hand in Glove with Automatic Pipette and Samples, Panoramic Image. Polymerase Chain Reaction PCR Used in Medical Testing, Biochemistry, Molecular Biology, Genetics, Clinical Research in Laboratory.


Join arterioscope in a fast growing market for diabetes related healthcare technologies.

“Our mission is to harness cutting-edge technology in advancing medical diagnostics, empowering diabetes patients to live healthier lifes.”

Our Scientific and Business Partners

Meet the Founders

Hermann Moser, MA MA

Co-Founder & CEO

Dr. Vahid Badeli

Co-Founder & CTO

DI Dr. Sascha Ranftl

Co-Founder & CSO

Our Company Story

Since its inception in 2018 at the Technical University of Graz (TU-Graz) as a strategic lead project, arterioscope's technology has evolved through the dedication of exceptional scientists and entrepreneurs. By 2024, this collaborative effort culminated in the launch of a trailblazing start-up, transforming our innovative technology into a valuable asset for both the industry and society.

Digital Twin

Imaging Technology

Aorta Bloodflow Simulation

Get in touch

Please send us a message via Email to discuss partnership opportunities.

We are currently also raising capital from new investors.


Stremayrgasse 16 / 4th Floor

8010 Graz



©️2024 arterioscope. All rights reserved.